Related Experiment Video
Updated: Jul 13, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
Kelley M Argraves1, W Scott Argraves
1Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston, SC 29425, USA. argravek@musc.edu
Insights
Sphingosine 1-phosphate (S1P), found in HDL, regulates cardiovascular health by influencing blood vessel function and reducing inflammation. This molecule plays a key role in protecting against heart damage and atherosclerosis.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Immunology
Background:
- High-density lipoprotein (HDL) possesses cardioprotective properties.
- Lysosphingolipid sphingosine 1-phosphate (S1P) is a bioactive lipid component of HDL.
Purpose of the Study:
- To review the evidence on S1P's role as a mediator of HDL's cardiovascular effects.
- To summarize S1P's regulation of vascular cell and lymphocyte behaviors in cardiovascular physiology and pathology.
Main Methods:
- Literature review of studies investigating S1P and HDL.
- Analysis of S1P's involvement in vasodilation, vasoconstriction, angiogenesis, and ischemia/reperfusion injury.
- Examination of S1P's anti-inflammatory and anti-atherosclerotic mechanisms.
Main Results:
- S1P mediates HDL's effects on vascular tone and angiogenesis.
- S1P protects against ischemia/reperfusion injury.
- S1P suppresses inflammatory processes, reduces adhesion molecule expression, and inhibits cardiomyocyte apoptosis, thereby inhibiting/reversing atherosclerosis.
Conclusions:
- S1P is a critical mediator of HDL's cardioprotective functions.
- S1P regulates vascular and immune cell behavior relevant to cardiovascular health.
- Targeting S1P pathways may offer therapeutic strategies for cardiovascular diseases.
Abstract:
The lysosphingolipid sphingosine 1-phosphate (S1P) is a component of HDL. Findings from a growing number of studies indicate that S1P is a mediator of many of the cardiovascular effects of HDL, including the ability to promote vasodilation, vasoconstriction, and angiogenesis, protect against ischemia/reperfusion injury, and inhibit/reverse atherosclerosis. These latter cardioprotective effects are being shown to involve the S1P-mediated suppression of inflammatory processes, including reduction of the endothelial expression of monocyte and lymphocyte adhesion molecules, decreased recruitment of polymorphonuclear cells to sites of infarction, and blocking of cardiomyocyte apoptosis after myocardial infarction. This review article summarizes the evidence that S1P as a component of HDL serves to regulate vascular cell and lymphocyte behaviors associated with cardiovascular (patho)physiology.
Related Concept Videos
Nitric Oxide Signaling Pathway
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Paracrine Signaling
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Heart Failure II: Pathophysiology
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...